Transcat (NASDAQ:TRNS) Reaches New 1-Year Low – Time to Sell?

Transcat, Inc. (NASDAQ:TRNS)’s share price reached a new 52-week low during trading on Tuesday . The company traded as low as $80.30 and last traded at $82.34, with a volume of 33464 shares traded. The stock had previously closed at $99.13.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on TRNS shares. HC Wainwright reissued a “buy” rating and set a $156.00 price objective on shares of Transcat in a research note on Tuesday, October 29th. Northland Securities dropped their price objective on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research note on Wednesday, October 30th. Oppenheimer reissued an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. Craig Hallum lifted their price objective on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Finally, StockNews.com downgraded Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $130.25.

Transcat Stock Down 23.8 %

The stock has a market cap of $694.65 million, a PE ratio of 39.02 and a beta of 0.71. The company has a fifty day moving average price of $105.34 and a 200 day moving average price of $115.41.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.36% and a net margin of 6.63%. During the same quarter in the prior year, the firm posted $0.56 EPS. As a group, research analysts predict that Transcat, Inc. will post 2.44 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. nVerses Capital LLC purchased a new position in Transcat during the 3rd quarter valued at about $60,000. US Bancorp DE increased its holdings in Transcat by 15.6% during the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after purchasing an additional 209 shares during the period. Captrust Financial Advisors bought a new stake in Transcat during the 3rd quarter valued at approximately $201,000. SG Americas Securities LLC bought a new stake in Transcat during the 4th quarter valued at approximately $182,000. Finally, Walleye Capital LLC bought a new stake in Transcat during the 3rd quarter valued at approximately $216,000. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.